Relaciones activas
Nombre | Sexo | Edad | Empresas relacionadas | Colaboración |
---|---|---|---|---|
Marc Cusachs | M | - |
Kintsugi Therapeutics
Kintsugi Therapeutics Pharmaceuticals: MajorHealth Technology Kintsugi Therapeutics is a biomedical start-up based in Barcelona, Spain. The Spanish company focuses on developing innovative therapies for the treatment of liver conditions and other pathologies by targeting the regulation of endoplasmic reticulum stress. The company's lead candidate is a first-in-class endoplasmic reticulum stress inhibitor being developed for the treatment of non-alcoholic steatohepatitis (NASH). The company was founded by Carmen Herrero and Marc Cusachs, with Carmen Herrero serving as the CEO since incorporation. | - |
Luis Antonio Ruiz-Avila | M | - |
Kintsugi Therapeutics
Kintsugi Therapeutics Pharmaceuticals: MajorHealth Technology Kintsugi Therapeutics is a biomedical start-up based in Barcelona, Spain. The Spanish company focuses on developing innovative therapies for the treatment of liver conditions and other pathologies by targeting the regulation of endoplasmic reticulum stress. The company's lead candidate is a first-in-class endoplasmic reticulum stress inhibitor being developed for the treatment of non-alcoholic steatohepatitis (NASH). The company was founded by Carmen Herrero and Marc Cusachs, with Carmen Herrero serving as the CEO since incorporation. | - |
Antonio Parente | M | - |
Kintsugi Therapeutics
Kintsugi Therapeutics Pharmaceuticals: MajorHealth Technology Kintsugi Therapeutics is a biomedical start-up based in Barcelona, Spain. The Spanish company focuses on developing innovative therapies for the treatment of liver conditions and other pathologies by targeting the regulation of endoplasmic reticulum stress. The company's lead candidate is a first-in-class endoplasmic reticulum stress inhibitor being developed for the treatment of non-alcoholic steatohepatitis (NASH). The company was founded by Carmen Herrero and Marc Cusachs, with Carmen Herrero serving as the CEO since incorporation. | - |
Eduard Goñalons | M | - |
Kintsugi Therapeutics
Kintsugi Therapeutics Pharmaceuticals: MajorHealth Technology Kintsugi Therapeutics is a biomedical start-up based in Barcelona, Spain. The Spanish company focuses on developing innovative therapies for the treatment of liver conditions and other pathologies by targeting the regulation of endoplasmic reticulum stress. The company's lead candidate is a first-in-class endoplasmic reticulum stress inhibitor being developed for the treatment of non-alcoholic steatohepatitis (NASH). The company was founded by Carmen Herrero and Marc Cusachs, with Carmen Herrero serving as the CEO since incorporation. | - |
Gráfico relacional
Relaciones con varias empresas
Estadísticas
País | Relaciones | % del total |
---|---|---|
España | 4 | 100.00% |
Antigüedad de la relación
Activas
Pasados
Hombre
Mujer
Administradores
Ejecutivos
Origen de las relaciones
- Bolsa de valores
- Insiders
- Carmen Herrero
- Red Personal